Elisa
Herráez Aguilar
Profesora Permanente Laboral
Oscar
Briz Sánchez
Profesor Permanente Laboral
Oscar Briz Sánchez-rekin lankidetzan egindako argitalpenak (25)
2023
-
Relevance of the organic anion transporting polypeptide 1B3 (OATP1B3) in the personalized pharmacological treatment of hepatocellular carcinoma
Biochemical Pharmacology, Vol. 214
-
Role of organic cation transporter 3 (OCT3) in the response of hepatocellular carcinoma to tyrosine kinase inhibitors
Biochemical Pharmacology, Vol. 217
2022
-
Beneficial effect of ursodeoxycholic acid in patients with acyl-CoA oxidase 2 (ACOX2) deficiency–associated hypertransaminasemia
Hepatology, Vol. 76, Núm. 5, pp. 1259-1274
-
Expression of Chemoresistance-Associated ABC Proteins in Hepatobiliary, Pancreatic and Gastrointestinal Cancers
Cancers, Vol. 14, Núm. 14
-
Impact of Liver Inflammation on Bile Acid Side Chain Shortening and Amidation
Cells, Vol. 11, Núm. 24
-
Mechanisms of Pharmacoresistance in Hepatocellular Carcinoma: New Drugs but Old Problems
Seminars in Liver Disease, Vol. 42, Núm. 1, pp. 087-103
2021
-
Synthetic Conjugates of Ursodeoxycholic Acid Inhibit Cystogenesis in Experimental Models of Polycystic Liver Disease
Hepatology, Vol. 73, Núm. 1, pp. 186-203
2020
-
Cellular mechanisms accounting for the refractoriness of colorectal carcinoma to pharmacological treatment
Cancers, Vol. 12, Núm. 9, pp. 1-34
-
Molecular bases of mechanisms accounting for drug resistance in gastric adenocarcinoma
Cancers, Vol. 12, Núm. 8, pp. 1-29
-
Sensitizing gastric adenocarcinoma to chemotherapy by pharmacological manipulation of drug transporters
Biochemical Pharmacology, Vol. 171
2019
-
Models for understanding resistance to chemotherapy in liver cancer
Cancers, Vol. 11, Núm. 11
2018
-
Chemoresistance and chemosensitization in cholangiocarcinoma
Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1864, Núm. 4, pp. 1444-1453
-
Genetic heterogeneity of SLC22 family of transporters in drug disposition
Journal of Personalized Medicine, Vol. 8, Núm. 2
-
Molecular bases of the poor response of liver cancer to chemotherapy
Clinics and Research in Hepatology and Gastroenterology
-
Role of drug transporters in the sensitivity of acute myeloid leukemia to sorafenib
Oncotarget, Vol. 9, Núm. 47, pp. 28474-28485
2017
-
ACOX2 deficiency: An inborn error of bile acid synthesis identified in an adolescent with persistent hypertransaminasemia
Journal of Hepatology, Vol. 66, Núm. 3, pp. 581-588
-
Usefulness of the MRP2 promoter to overcome the chemoresistance of gastrointestinal and liver tumors by enhancing the expression of the drug transporter OATP1B1
Oncotarget, Vol. 8, Núm. 21, pp. 34617-34629
2016
-
Biodetection of potential genotoxic pollutants entering the human food chain through ashes used in livestock diets
Food Chemistry, Vol. 205, pp. 81-88
2014
-
Cocarcinogenic effects of intrahepatic bile acid accumulation in cholangiocarcinoma development
Molecular Cancer Research, Vol. 12, Núm. 1, pp. 91-100
2013
-
Activation of the nuclear receptor FXR enhances hepatocyte chemoprotection and liver tumor chemoresistance against genotoxic compounds
Biochimica et Biophysica Acta - Molecular Cell Research, Vol. 1833, Núm. 10, pp. 2212-2219